ASX:RAC - Switzer TV | Stocks slide, is now the time to buy anyway? Red flags for SpaceX IPO

Racura Oncology InvestorHub

Switzer TV | Stocks slide, is now the time to buy anyway? Red flags for SpaceX IPO

Daniel Tillett, Racura Oncology: the Australian biotech that says it has cracked a cancer target left untouched for 40 years, and why its shareholders keep backing it.

Watch below:

Your question will be sent privately to Racura Oncology. The company may choose to make this question public.

Start the conversation

Ask Racura Oncology a question about this update.

Share your feedback

Discover